Beckman Coulter Life Sciences is a trusted, worldwide resource to optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. All these products continue to make a difference by improving the productivity of dedicated scientists, quality control experts and others. From prestigious universities and major pharmaceutical companies to small biotech startups, food/beverage and electronics manufacturing facilities, you can find our name everywhere. Learn more.

 Press Releases

• MET ONE 3400+ air particle counter honored with awards (Feb 17, 2021)

  Timely launch during a pandemic underscores instrument’s use in biopharma production

  (Indianapolis, IN – February 3, 2021) – Celebrating more than 85 years of innovation, Beckman Coulter Life Sciences is honored to announce a pair of awards for its MET ONE 3400+ air particle counter less than a year after its successful launch.

  In late 2020, editors of Pharma Manufacturing honored the new MET ONE 3400+ air particle counter with a 2020 Pharma Innovation Award. Weeks later, editors at The Analytical Scientist likewise bestowed one of their 2020 Innovation Awards on the MET ONE 3400+ instrument.

  According to Karen Langhauser, chief content director for Pharma Manufacturing, its awards are “intended to recognize recently launched or updated technologies, systems and services for the potential value and innovation they bring to the pharma industry.”

  Matthew Hallam, editor of The Analytical Scientist notes that their innovation awards “continue to paint an exciting picture of the future – and the instruments and technologies that are likely to have an impact across analytical science.”

  Launched in early summer of 2020, the MET ONE 3400+ was designed to help improve data integrity and access—as well as reduce human error—for routine environmental monitoring, which can be critical for global biopharma manufacturing, including vaccine production.

  “We’re extremely honored to receive both these 2020 innovation awards,” says Product Manager Tony Harrison. “We were especially excited to introduce this easier-to-use portable monitor at a particularly challenging time for the biopharmaceutical industry.

  Added Greg Milosevich, President of Beckman Coulter Life Sciences, “A big part of our mission is to help customers quickly get the accurate data they need to achieve their objectives. Because it lets QC managers monitor cleanroom data remotely and at any time of day, using a standard web browser, the MET ONE 3400+ truly embodies our mission.”

  Among many other innovative features, the MET ONE 3400+ enables interactive, on-screen tracking that instantly shows users which locations have been sampled so they can monitor their progress at a glance. All reports can be exported in a secure electronic format to the user’s network or a USB device, which means the MET ONE 3400+ supports compliance with the FDA’s 21 CFR Part 11 regulation, and it can help make data access fast and efficient during audits required to maintain GMP manufacturing status.

  “To help simplify cleanroom monitoring for FDA and GMP compliance,” Harrison says, “we made a lot of innovative enhancements to our previous MET ONE portable monitor. Receiving both of these Innovation Awards certainly helps confirm the value these enhancements can bring to all manufacturers that use cleanrooms in their production process.”

• Beckman Coulter Life Sciences Acquires Microbioreactor Manufacturer m2p-labs (Feb 17, 2021)

  (Indianapolis, Indiana - November 12, 2020) - Beckman Coulter Life Sciences signed a definitive agreement to acquire m2p-labs, a privately held, microbioreactor manufacturer based in Baesweiler, Germany. m2p-labs is best known for its transformative BioLector plate-based microbioreactors, which support automated solutions for screening and bioprocess development.

  “Innovation defines our future,” said Greg Milosevich, President, Beckman Coulter Life Sciences. “m2p-labs core product line complements our existing cell health, liquid handling and laboratory automation business. Our collective team has the opportunity to enhance time-saving solutions for cell line development and process development workflows.”

  “m2p-labs and Beckman Coulter Life Sciences share a common vision of accelerating answers, enabling the faster discovery and development of life-changing advances in medicine,” said, Matthias Eggers, Managing Director, m2p-labs. “We are excited to join, and expand, a powerful team to provide invaluable resources to biologics customers around the world.”

  m2p-labs was supported in several financings rounds by FIDURA Private Equity Funds and High-Tech Gründerfonds. “It was a privilege for us to work with management on growing m2p-labs to a leading microbioreactor vendor with global reach,” said Klaus Ragotzky, Managing Director and Chairman of the Advisory Board, FIDURA.

  m2p-labs associates and products will transition into Beckman Coulter Life Sciences’ Biotechnology Business Unit. The company’s existing Baesweiler, Germany site will remain operational.

  About m2p labs GmbH

  Based in Baesweiler, Germany (near Aachen), the company was founded in November 2005 as a spin-off of RWTH Aachen University. The company name was derived from the explanation "from microreactor to process" what the m2p-labs systems are used for in laboratories. The company focuses on microreaction and automated solutions for screening and bioprocess development. Our commercialized products are the BioLector, the BioLector Pro, and the FlowerPlate, which provide an intelligent micro fermentation platform. This proprietary technology empowers the biotechnology, chemical, and pharmaceutical industries to increase the number and the information content of microbial experiments (aerobic, microaerophilic, and strictly anaerobic). It enables customers to conduct experiments with high efficiency and excellent quality in microscale at low costs.

 Products